Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98

被引：1
|
作者：
Dieter Koeberle
Beat Thuerlimann
机构：
[1] Kantonsspital,Department of Internal Medicine, Division Oncology/Hematology
来源：
Breast Cancer Research and Treatment | 2008年 / 112卷 / 2期
关键词：
D O I：
10.1007/s10549-007-9858-3
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：387 / 387
相关论文
共 50 条
  • [1] Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98
    Dieter Koeberle
    Beat Thuerlimann
    Breast Cancer Research and Treatment, 2007, 105 : 55 - 66
  • [2] Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98
    Koeberle, Dieter
    Thuerlimann, Beat
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 105 (Suppl 1) : 55 - 66
  • [3] The Breast International Group 1-98 trial: big results for women with hormone-sensitive early breast cancer
    Monnier, Alain M.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (05) : 627 - 634
  • [4] Five years of continuous letrozole versus tamoxifen as adjuvant therapy for postmenopausal women with endocrine-responsive breast cancer:: Further analyses and update of BIG 1-98
    Coates, Alan S.
    Keshaviah, Aparna
    Thuerlimann, Beat
    Mouridsen, Henning
    Mauriac, Louis
    Paridaens, Robert
    Castiglione-Gertsch, Monica
    Gelber, Richard D.
    Smith, Ian
    Goldhirsch, Aron
    ANNALS OF ONCOLOGY, 2006, 17 : 93 - 94
  • [5] Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer:: Update of study BIG 1-98
    Coates, Alan S.
    Keshaviah, Aparna
    Thuerlimann, Beat
    Mouridsen, Henning
    Mauriac, Louis
    Forbes, John F.
    Paridaens, Robert
    Castiglione-Gertsch, Monica
    Gelber, Richard D.
    Colleoni, Marco
    Lang, Istvan
    Del Mastro, Lucia
    Smith, Ian
    Chirgwin, Jacquie
    Nogaret, Jean-Marie
    Pienkowski, Tadeusz
    Wardley, Andrew
    Jakobsen, Erik H.
    Price, Karen N.
    Goldhirsch, Aron
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) : 486 - 492
  • [6] Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial
    Phillips, Kelly-Anne
    Ribi, Karin
    Sun, Zhuoxin
    Stephens, Alisa
    Thompson, Alastair
    Harvey, Vernon
    Thuerlimann, Beat
    Cardoso, Fatima
    Pagani, Olivia
    Coates, Alan S.
    Goldhirsch, Aron
    Price, Karen N.
    Gelber, Richard D.
    Bernhard, Juerg
    BREAST, 2010, 19 (05): : 388 - 395
  • [7] Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial
    Phillips, Kelly-Anne
    Aldridge, Julie
    Ribi, Karin
    Sun, Zhuoxin
    Thompson, Alastair
    Harvey, Vernon
    Thuerlimann, Beat
    Cardoso, Fatima
    Pagani, Olivia
    Coates, Alan S.
    Goldhirsch, Aron
    Price, Karen N.
    Gelber, Richard D.
    Bernhard, Juerg
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 126 (01) : 221 - 226
  • [8] Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial
    Kelly-Anne Phillips
    Julie Aldridge
    Karin Ribi
    Zhuoxin Sun
    Alastair Thompson
    Vernon Harvey
    Beat Thürlimann
    Fatima Cardoso
    Olivia Pagani
    Alan S. Coates
    Aron Goldhirsch
    Karen N. Price
    Richard D. Gelber
    Jürg Bernhard
    Breast Cancer Research and Treatment, 2011, 126 : 221 - 226
  • [9] Letrozole vs. tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive breast cancer. Update of the BIG 1-98 primary core analysis
    Thuerlimann, B.
    BREAST, 2009, 18 : S60 - S60
  • [10] Predictors of early recurrence in postmenopausal women with hormone receptor positive breast cancer in the BIG 1-98 trial
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 111 - 111
12345